Stockscreener 앱 받기
16.07
0.56%
0.09
시간 외 거래:
16.07
전일 마감가:
$15.98
열려 있는:
$15.93
하루 거래량:
732.90K
Relative Volume:
0.59
시가총액:
$1.40B
수익:
$12.59M
순이익/손실:
$-212.39M
주가수익비율:
-5.2086
EPS:
-3.0853
순현금흐름:
$-185.92M
1주 성능:
+2.42%
1개월 성능:
+37.23%
6개월 성능:
+82.82%
1년 성능:
+40.10%
1일 변동 폭
$15.64
$16.43
1주일 범위
$15.36
$17.20
52주 변동 폭
$5.1501
$17.32
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
16.07 | 1.39B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 개시 | Goldman | Buy |
| 2025-09-05 | 개시 | Craig Hallum | Buy |
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference - The AI Journal
Is Immunome Inc. stock bottoming outJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
Using economic indicators to assess Immunome Inc. potentialMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com
Will Immunome Inc. stock reach Wall Street targetsStock Surge & Safe Entry Momentum Tips - newser.com
Historical volatility pattern of Immunome Inc. visualized2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
What technical signals suggest for Immunome Inc. stock2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Evaluating Immunome Inc. with trendline analysis2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Is Immunome Inc. stock a safe haven assetFed Meeting & Fast Gain Stock Trading Tips - newser.com
Immunome Bets Big On Cancer Drugs As Shares Outpace The Market - Finimize
How Immunome Inc. stock benefits from tech adoptionWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Aug Highlights: How Immunome Inc. stock benefits from tech adoptionMarket Activity Recap & Fast Moving Stock Trade Plans - Fundação Cultural do Pará
Immunome (NASDAQ:IMNM) Trading 8.3% HigherTime to Buy? - MarketBeat
Will Immunome Inc. stock outperform Nasdaq indexInsider Selling & Proven Capital Preservation Tips - Fundação Cultural do Pará
Can Immunome Inc. stock beat analyst upgradesEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Fundação Cultural do Pará
Why Immunome Inc. stock is popular among millennialsLayoff News & AI Driven Stock Price Forecasts - Fundação Cultural do Pará
Can machine learning forecast Immunome Inc. recoveryJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Immunome’s Phase 1 Cancer Study: A Potential Game-Changer? - TipRanks
Chart overlay techniques for tracking Immunome Inc.Weekly Profit Report & Community Trade Idea Sharing - newser.com
How Immunome Inc. stock performs in rate cut cycles2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Immunome's (IMNM) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $428,000 Position in Immunome, Inc. $IMNM - MarketBeat
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):